Skip to Main Content

Paper Details

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
Nat Immunol
331
2018
Author NameAffiliation
Aaron M RingYale University School of Medicine
  • 1 - 1

Datasets

Release 1.2